PATENT CLAIM ANALYSIS

Application Number: 16044653
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-07
Patent Classification: ["544", "281000"]

Abstract:
Compounds useful in the synthesis of compounds for treating pain, cancer, inflammation, neurodegenerative disease or Typanosoma cruzi infection in a mammal.

Claim (Index 2):
A method for attenuating or ameliorating one or more symptoms of a cancer in a mammal in need thereof, the method comprising administering to the mammal a therapeutically effective amount of a compound of Formula (I): or a pharmaceutically acceptable salt thereof, wherein:\n R 1  is H or (1-6C alkyl); \n R 2  is NR b R c ; \n NR b R c  forms a 5-membered heterocyclic ring optionally substituted with one or two substituents independently selected from OH and (1-4C)alkyl; \n Y is phenyl optionally substituted with one or more substituents independently selected from halogen, (1-4C)alkoxy, CF 3  and CHF 2 ; \n X is \u2014CH 2 \u2014; \n R 3  is H or (1-4C alkyl); \n each R 4  is independently selected from halogen, (1-4C)alkyl, OH, (1-4C)alkoxy, NH 2 , NH(1-4C alkyl) and CH 2 OH; and \n n is 0, 1, or 2, \n wherein the cancer exhibits one or more of overexpression, activation, amplification, and mutation of a Trk kinase.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 95.0
- Lexical Diversity: 1.13636
- Patent Class: 544.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14846166', '14490460', '15399389', '15860948', '13943590']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7842730441509632
- 35 USC 102 Novelty (BERT): 0.6068649412958221
- Combined Prediction Score: 0.7665322338654492
- Mean Citation Score: 516.280366
- Max Citation Score: 538.1641
- Similarity Product: 498.2058738923192

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test